Our Timeline – Journey of Progress
EndoCare Therapeutics is a pioneering company that emerged with a clear vision to address the pressing need for a cost-effective, fast, and non-invasive diagnostic method for endometriosis. With a firm commitment to improving the lives of women worldwide, we embarked on a transformative timeline journey that has since been marked by breakthroughs and unwavering dedication.
2023 – Discovery
EndoCare Therapeutics Timeline begins in 2023 when our women-funded and led company was discovered in 2023, after recognising the need of a cost-effective, fast, non-invasive diagnostic method for endometriosis.
2024 | 2025 – Pre-Clinical Tests
We will perform molecular assays to test blood biomarkers for endometriosis. The biomarkers will be tested separately and in combination for a highly specific diagnosis.
2025 – Prototype Development
The assay with the highest specificity will be chosen and the prototype will be established.
2025 | 2026 – Clinical Trials
We will test our diagnostic method in phase 2 and 3 clinical trials to evaluate effectiveness, and compare our test to others.
2027 – Commercialisation
The EndoCare Therapeutics Timeline culminates with the test being successfully launched on the market, providing a much-needed solution for non-invasive endometriosis diagnosis.
Learn more About Endometriosis ↗
In Hungarian